Aromatase Inhibitors for Ovulation Induction | Zendy

Stefano Palomba | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aromatase Inhibitors for Ovulation Induction

Author(s) -

Stefano Palomba

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-4235

Subject(s) - letrozole , anovulation , aromatase , polycystic ovary , ovulation induction , medicine , aromatase inhibitor , infertility , endocrinology , ovulation , metformin , gynecology , randomized controlled trial , pregnancy , hormone , biology , diabetes mellitus , insulin resistance , breast cancer , cancer , genetics

Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research